Mimedx (MDXG) EPS (Diluted) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EPS (Diluted) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 13.96% |
| 10 | Mimedx | 671.73 Mn | 535.89 Mn | 44.38 Mn | -255.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -255.88% |
| Mar 31, 2026 | -255.92% |
| Dec 31, 2025 | 103.31% |
| Sep 30, 2025 | 110.69% |
| Jun 30, 2025 | -45.57% |
| Mar 31, 2025 | -22.31% |
| Dec 31, 2024 | -83.75% |
| Sep 30, 2024 | -10.37% |
| Jun 30, 2024 | 82.27% |
| Mar 31, 2024 | 290.54% |
| Dec 31, 2023 | 326.33% |
| Sep 30, 2023 | 166.57% |
| Jun 30, 2023 | 158.65% |
| Mar 31, 2023 | 70.70% |
| Dec 31, 2022 | 668.66% |
| Sep 30, 2022 | -151.80% |
| Jun 30, 2022 | -272.68% |
| Mar 31, 2022 | -20.16% |
| Dec 31, 2021 | 92.41% |
| Sep 30, 2021 | 92.62% |